and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ADMA Biologics Inc Stock Price (Quote) NASDAQ:ADMA
$2.13 ( 4.93% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.85 | $2.32 | Tuesday, 5th Jul 2022 ADMA stock ended at $2.13. This is 4.93% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 8.08% from a day low at $1.98 to a day high of $2.14. |
| 90 days | $1.43 | $2.32 | |
| 52 weeks | $1.01 | $2.32 |
Historical ADMA Biologics Inc prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $1.98 | $2.14 | $1.98 | $2.13 | 2 027 313 |
| 2022-07-01 | $2.00 | $2.05 | $1.96 | $2.03 | 1 768 606 |
| 2022-06-30 | $1.96 | $1.98 | $1.90 | $1.98 | 2 031 991 |
| 2022-06-29 | $2.01 | $2.03 | $1.92 | $1.96 | 3 363 996 |
| 2022-06-28 | $2.15 | $2.18 | $2.00 | $2.02 | 2 361 217 |
| 2022-06-27 | $2.02 | $2.16 | $1.98 | $2.16 | 3 270 826 |
| 2022-06-24 | $2.08 | $2.09 | $1.90 | $1.94 | 26 158 297 |
| 2022-06-23 | $2.15 | $2.23 | $2.05 | $2.07 | 2 792 332 |
| 2022-06-22 | $2.11 | $2.20 | $2.10 | $2.15 | 2 764 345 |
| 2022-06-21 | $2.20 | $2.32 | $2.13 | $2.13 | 4 257 973 |
| 2022-06-17 | $2.03 | $2.20 | $2.01 | $2.20 | 4 030 691 |
| 2022-06-16 | $1.97 | $2.07 | $1.91 | $2.03 | 3 059 564 |
| 2022-06-15 | $1.91 | $2.03 | $1.91 | $2.03 | 1 697 059 |
| 2022-06-14 | $1.91 | $1.97 | $1.88 | $1.95 | 1 261 286 |
| 2022-06-13 | $1.90 | $1.96 | $1.85 | $1.90 | 2 229 885 |
| 2022-06-10 | $2.04 | $2.04 | $1.94 | $1.94 | 1 491 269 |
| 2022-06-09 | $2.15 | $2.15 | $2.05 | $2.08 | 2 259 092 |
| 2022-06-08 | $1.98 | $2.19 | $1.97 | $2.15 | 3 847 908 |
| 2022-06-07 | $1.89 | $2.02 | $1.87 | $2.01 | 2 857 584 |
| 2022-06-06 | $2.02 | $2.05 | $1.87 | $1.88 | 1 928 949 |
| 2022-06-03 | $2.03 | $2.05 | $1.98 | $2.01 | 1 478 959 |
| 2022-06-02 | $2.02 | $2.06 | $1.95 | $2.04 | 1 952 809 |
| 2022-06-01 | $2.08 | $2.08 | $1.97 | $2.04 | 1 949 814 |
| 2022-05-31 | $2.04 | $2.14 | $2.01 | $2.05 | 3 289 115 |
| 2022-05-27 | $1.96 | $2.09 | $1.91 | $2.04 | 2 011 507 |
| 2022-05-26 | $1.93 | $1.99 | $1.84 | $1.94 | 1 801 343 |
| 2022-05-25 | $1.86 | $1.96 | $1.85 | $1.93 | 880 917 |
| 2022-05-24 | $2.05 | $2.05 | $1.82 | $1.84 | 1 974 939 |
| 2022-05-23 | $2.06 | $2.10 | $2.01 | $2.07 | 1 441 763 |
| 2022-05-20 | $2.07 | $2.07 | $1.99 | $2.04 | 1 529 209 |
| 2022-05-19 | $1.99 | $2.09 | $1.98 | $2.05 | 2 293 254 |
| 2022-05-18 | $1.99 | $2.10 | $1.93 | $2.01 | 2 607 566 |
| 2022-05-17 | $1.88 | $2.03 | $1.88 | $2.02 | 3 199 644 |
| 2022-05-16 | $1.73 | $1.90 | $1.71 | $1.87 | 2 776 584 |
| 2022-05-13 | $1.74 | $1.76 | $1.66 | $1.76 | 2 624 627 |
| 2022-05-12 | $1.43 | $1.75 | $1.43 | $1.68 | 4 588 716 |
| 2022-05-11 | $1.58 | $1.62 | $1.43 | $1.43 | 2 949 951 |
| 2022-05-10 | $1.60 | $1.65 | $1.57 | $1.61 | 2 654 020 |
| 2022-05-09 | $1.78 | $1.78 | $1.52 | $1.54 | 3 816 903 |
| 2022-05-06 | $1.86 | $1.88 | $1.77 | $1.79 | 2 320 008 |
| 2022-05-05 | $1.97 | $1.99 | $1.85 | $1.88 | 3 607 815 |
| 2022-05-04 | $1.95 | $2.01 | $1.84 | $1.98 | 3 596 568 |
| 2022-05-03 | $1.90 | $1.99 | $1.88 | $1.94 | 2 605 441 |
| 2022-05-02 | $1.84 | $1.92 | $1.82 | $1.89 | 4 646 953 |
| 2022-04-29 | $1.89 | $1.97 | $1.82 | $1.84 | 4 490 514 |
| 2022-04-28 | $1.98 | $1.98 | $1.79 | $1.89 | 4 494 122 |
| 2022-04-27 | $1.89 | $1.99 | $1.88 | $1.98 | 1 923 306 |
| 2022-04-26 | $1.94 | $1.98 | $1.89 | $1.92 | 1 358 754 |
| 2022-04-25 | $1.96 | $2.02 | $1.90 | $1.97 | 2 044 153 |
| 2022-04-22 | $2.00 | $2.01 | $1.93 | $2.00 | 898 742 |
ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
